On the afternoon of July 17, 2024, the 2024 Salon for Diplomatic Envoys, Chambers of Commerce and Foreign-Funded Enterprises in Beijing's "Two Zones" was held in Haidian. At the event, Novozymes (China) Investment Co., Ltd., a key foreign-funded enterprise in Haidian, was recognized among Beijing's first "Global Service Partners" for its outstanding biological solutions and global services.
A subsidiary of Novonesis, Novozymes is headquartered in Denmark, with its China regional headquarters located in Haidian. As one of the first biotechnology enterprises to establish an R&D center in China, it has previously been recognized as a "Regional Headquarters of a Multinational Corporation" and a "Foreign-Funded R&D Headquarters" by the Beijing Municipal Commerce Bureau. As a global leader in biological solutions, Novozymes is committed to improving industrial efficiency and protecting the Earth's resources through innovative enzyme and microbial preparations. On January 29, 2024, Novozymes merged with Chr. Hansen to form Novonesis, aiming to build a world-leading partner in biological solutions.
Moving forward, Haidian District will closely focus on the goal of high-quality development, continuously optimize its business environment, strengthen services and support for foreign-funded enterprises, and contribute to the development of foreign-funded enterprises in Haidian for Beijing's economic and social development.
